CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Low-dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma
You Joung Heo, Jae Ho Yoo, Yun Soo Choe, Sang Hee Park, Seung Bok Lee, Hyun A Kim, Jung Yoon Choi, Young Ah Lee, Byung Chan Lim, Hee Won Chueh
Ann Pediatr Endocrinol Metab. 2022;27(3):236-241.   Published online October 18, 2021
DOI: https://doi.org/10.6065/apem.2142044.022

Excel Download

Low-dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma
You Joung Heo, Jae Ho Yoo, Yun Soo Choe, Sang Hee Park, Seung Bok Lee, Hyun A Kim, Jung Yoon Choi, Young Ah Lee, Byung Chan Lim, Hee Won Chueh
Annals of Pediatric Endocrinology & Metabolism. 2022;27(3):236-241   Crossref logo
Link1 Link2 Link3
High-Dose Mitotane-Induced Encephalopathy in the Treatment of Adrenocortical Carcinoma
Elise Pape, Catherine Feliu, Mélissa Yéléhé-Okouma, Natacha Colling, Zoubir Djerada, Nicolas Gambier, Georges Weryha, Julien Scala-Bertola
The Oncologist. 2017;23(3):389-390   Crossref logo
Link1 Link2 Link3 Link4
Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane
I. Ilias, M. Alevizaki, G. Philippou, E. Anastasiou, A. Souvatzoglou
Journal of Endocrinological Investigation. 2001;24(7):532-535   Crossref logo
Link1 Link2 Link3
LONG-TERM FOLLOW-UP OF ADRENOCORTICAL CARCINOMA PATIENTS TREATED WITH ADJUVANT LOW-DOSE MITOTANE (O, P', -DDD)
M. Mullerad, G. Dickstein, C. Shechner, G. Meyer, B. Moskovitz, O. Nativ
European Urology Supplements. 2006;5(2):150   Crossref logo
Link1 Link2
Management of Mitotane Therapy in Adrenocortical Carcinoma
William Young, Irina Bancos
Adrenal Disorders. 2023;121-126   Crossref logo
Link1 Link2
Abstract #120: Case Report: Mitotane Induced Secondary Hypothyroidism in a Patient with Adrenocortical Carcinoma
Yunying Shi, Shalini Bhat
Endocrine Practice. 2015;21:11   Crossref logo
Link1 Link2
Management of adrenocortical carcinoma after failure of mitotane therapy
Salvatore Grisanti, Valentina Cremaschi, Alfredo Berruti
L'Endocrinologo. 2023;   Crossref logo
Link1 Link2 Link3
RECURRENT ADRENOCORTICAL CARCINOMA IN A 4 YEAR OLD GIRL
Ahmed H. Al-Salem, Hussain A. Abu-Srair
ANZ Journal of Surgery. 1994;64(10):723-725   Crossref logo
Link1 Link2
Mitotane Therapy in the ENSAT Stage II Adrenocortical Carcinoma
William Young, Irina Bancos
Adrenal Disorders. 2023;97-99   Crossref logo
Link1 Link2
The effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cells
B. Rubin, C. Pilon, R. Pezzani, A. Rebellato, F. Fallo
Journal of Endocrinological Investigation. 2019;43(3):357-367   Crossref logo
Link1 Link2 Link3